INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 71.50
-0.50 (-0.69%)
Dec 31, 2025, 8:00 AM GMT+1
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 72.7 million as of December 31, 2025. Its market cap has increased by 64.37% in one year.
Market Cap
72.70M
Enterprise Value
108.67M
Revenue
195.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
71.50
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 72.70M, a decrease of -47.30%. That is a compound annual growth rate of -10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 72.70M | 57.14% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.22B |
| GSK plc | 73.45B |
| Haleon | 33.27B |
| Smith & Nephew | 10.49B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.79B |
| Genus | 1.75B |